GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

NODK · Dec 31, 2023

NI Holdings, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001174947-24-000361Insurance
CashRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.cash

$56.7M · CORE · NOT_ENOUGH_HISTORY

Policy-benefit growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.insurance.policy_benefits

-16.99% · OPTIONAL · NOT_ENOUGH_HISTORY

DebtRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.gross_debt

$2.4M · OPTIONAL · NOT_ENOUGH_HISTORY

Premium growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.insurance.premiums

6.96% · CORE · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

12.72% · CORE · NOT_ENOUGH_HISTORY

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History15 statesSelf-history eligible
Period transition

What moved in the state?

Cash Increased
Previous
$34.5M
Current
$56.7M
Delta
$22.2M
Claims Growth Increased
Previous
-19.45%
Current
-16.99%
Delta
2.47%
Premium Growth Increased
Previous
1.38%
Current
6.96%
Delta
5.58%
Revenue Growth Increased
Previous
4.01%
Current
12.72%
Delta
8.71%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.